Moreover, the GAPDH and succinate dehydrogenase (SDH) in combination with the β-F1-ATPase/LDH-A ratio discriminate BMD (86% sensitivity) and LGMD-2C (100% sensitivity) diseases, respectively (Table 2). The gene discussed is GAPDH; the disease is limb-girdle muscular dystrophy.